Cargando…
Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16
Autores principales: | Gruber, Tanja A., Pei, Deqing, Choi, John, Cheng, Cheng, Coustan-Smith, Elaine, Campana, Dario, Swanson, Hope D., Pauley, Jennifer L., Inaba, Hiroto, Metzger, Monika L., Rubnitz, Jeffrey E., Ribeiro, Raul C., Raimondi, Susana C., Pui, Ching-Hon, Jeha, Sima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768237/ https://www.ncbi.nlm.nih.gov/pubmed/36251744 http://dx.doi.org/10.1182/bloodadvances.2022008557 |
Ejemplares similares
-
Long-term results of St. Jude Total Therapy studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia
por: Pui, C-H, et al.
Publicado: (2009) -
Clinical Impact of Minimal Residual Disease in Children with Different Subtypes of Acute Lymphoblastic Leukemia Treated with Response-Adapted Therapy
por: Pui, Ching-Hon, et al.
Publicado: (2016) -
Combination of Cladribine and Cytarabine is Effective for Childhood Acute Myeloid Leukemia: Results of the St. Jude AML97 Trial
por: Rubnitz, Jeffrey E., et al.
Publicado: (2009) -
Patient-Level Meta-analysis of Clofarabine in Acute Lymphoblastic Leukemia
por: Jeha, Sima, et al.
Publicado: (2023) -
Vaccines against SARS‐CoV‐2 are safe to administer in patients with antibodies to pegaspargase
por: Swanson, Hope D., et al.
Publicado: (2022)